Associate Professor, Section of Pharmaceutical Chemistry

Education

• 1987: Degree in Pharmacy‎
• ‎‎1992: PhD in ‎ Pharmaceutical Analysis
• ‎1993-1995: Post-doc in London School of Pharmacy

Teaching

• Undergraduate courses/labs: Pharmaceutical Analysis I, Laboratory of Pharmaceutical Analysis, Introduction to Laboratory Practice
• Graduate courses: Clinical Pharmaceutical Analysis, Statistics-Chemometrics

Research topics

• Pharmaceutical Analysis-Quality Control in formulations
• Bioanalysis with various analytical techniques
• Neonatal screening
• Experimental Design
• Molecular Analysis, Genomics, Molecular Oncology
• Bioinformatics

Distinctions

• Member of the Pharmaceutical Analysis Group (Royal Pharmaceutical Society, U.K.)
• Member of the Controlled Release Society (USA)‎
• Member of Region 4 Genetics MS/MS Collaborative consortium for neonatal ‎screening

‎

Recent publications

• Loukas YL, Thodi G, Molou E, Georgiou V, Dotsikas Y, Schulpis KH, Clinical diagnostic Next-Generation sequencing: the case of CFTR carrier screening. Scand. J. Clin. Lab. Invest. 75(2015) 374-381.
• Schulpis KH, Thodi G, Iakovou K, Chatzidaki M, Dotsikas Y, Molou E, Triantafylli O, Loukas YL, Clinical evaluation and mutational analysis of GALK and GALE genes in patients with galactosemia in Greece: one novel mutation and two rare cases. J. Pediatr. Endocrino.lMetab. 30 (2017) 775-779.
• Mizzi C, Dalabira E, Kumuthini J, Dzimiri N, Balogh I, Başak N, Böhm R, Borg J, Borgiani P, Bozina N, Bruckmueller H, Burzynska B, Carracedo A, Cascorbi I, Deltas C, Dolzan V, Fenech A, Grech G, Kasiulevicius V, Kádaši Ľ, Kučinskas V, Khusnutdinova E, Loukas YL, Macek M Jr, Makukh H, Mathijssen R, Mitropoulos K, Mitropoulou C, Novelli G, Papantoni I, Pavlovic S, Saglio G, Setric J, Stojiljkovic M, Stubbs AP, Squassina A, Torres M, Turnovec M, van Schaik RH, Voskarides K, Wakil SM, Werk A, Del Zompo M, Zukic B, Katsila T, Lee MT, Motsinger-Rief A, Mc Leod HL, van der Spek PJ, Patrinos GP, A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics. PLoS One 16 (2016)  e0162866.
• Katerina Iliou, AndelijaMalenović, Yannis L. Loukas, YannisDotsikas, Analysis of potential genotoxic impurities in rabeprazole active pharmaceutical ‎ingredient via Liquid Chromatography-tandem Mass Spectrometry, following ‎quality-by-design principles for method development. J. Pharm. Biomed. Anal. 149 (2018) 410-418‎
• Maria Koukoula, YannisDotsikas, Elina Molou, Kleopatra H. Schulpis, Georgia ‎Thodi, Maria Chatzidaki, Olga Triantafylli and Yannis L. Loukas, StudyoftheeffectofCYP2C19 polymorphismsonomeprazolepharmacokinetics‎byutilizingvalidatedLC-MS/MSandRealTime-PCRmethods. J. Chromatogr. Β 1047 (2017) 173-179‎
• AnargyrosFoivas, AnđelijaMalenović, NađaKostić, MarijaBožić, Miroslav ‎‎Knežević, Yannis L. Loukas, YannisDotsikas, QuantitationofbrinzolamideindriedbloodspotsbyanovelLC-QTOF-MS/MS‎method. J. Pharm. Biomed. Anal. 119 (2016) 84-90‎
• Nikolaos Kritikos, Anna Tsantili-Kakoulidou, Yannis L. Loukas, Yannis‎Dotsikas, Liquid Chromatography coupled to Quadrupole-Time of Flight Tandem Mass ‎‎Spectrometry based Quantitative Structure-Retention Relationships of amino ‎acid ‎analogues derivatized via n-propyl chloroformate mediated reaction. J. Chromatogr. A 1403 (2015) 70-80‎

Contact
Postal address: Section of Pharmaceutical Chemistry,
Department of Pharmacy,
National and Kapodistrian University of Athens,
Panepistimiopolis, 157 84
Athens, Greece
Tel.: +30(210) 727 4224
Fax: +30(210) 727 4224
e-mail:loukas@pharm.uoa.gr